Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

recurrent Vaginal Cancer

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Recurrent Vaginal Cancer

Broader topic: Vaginal Cancer

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Recurrent Vaginal Cancer

    Study evidence for this setting

    5 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00545792 · Registry condition search · Scope: unclear

    Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

    2 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00941070 · Registry condition search · Scope: unclear

    Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

    6 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT01079832 · Registry condition search · Scope: unclear

    Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

    5 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT03345784 · Registry condition search · Scope: unclear

    Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

    4 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT03439085 · Registry condition search · Scope: unclear

    DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated C

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice